SMT-NK

· SMTbio Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SMT-NK, covering 2022-03-29 to 2022-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer [Phase 1, Phase 2]

See pricing